Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
10
×
boulder/denver blog main
boulder/denver top stories
deals
10
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
10
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
10
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10
×
biotech
startups
alzheimer's disease
cancer immunotherapy
merck
cancer
investing
bayer
biogen
eli lilly
fda
gilead sciences
What
bio
roundup
drug
develop
pfizer’s
acquisitions
alzheimer’s
amid
biggest
billions
bombast
buy
cancer
caught
ceo
companies
coronavirus
crispr
debate
discussion
efforts
gene
growing
life
meso’s
millions
miss
moves
nash
news
pandemic
patients
pharmaceutical
presidential
promise
response
science
tuesday’s
typically
vaccine
Language
unset
unknown
Current search:
pfizer
×
deals
×
" wisconsin top stories "
×
national
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More